Focus on RAS codon 61 mutations in metastatic colorectal cancer (mCRC): A retrospective analysis

被引:0
|
作者
Schietroma, F. [1 ]
Anghelone, A. [2 ]
Valente, G. [1 ]
Beccia, V. [1 ]
Caira, G. [1 ]
Spring, A. [1 ]
Trovato, G. [1 ]
Di Bello, A. [1 ]
Ceccarelli, A. [1 ]
Chiofalo, L. [1 ]
Perazzo, S. [1 ]
Bensi, M. [1 ]
Basso, M. [1 ]
Pozzo, C. [1 ]
Salvatore, L. [1 ]
Calegari, M. [1 ]
Tortora, G. [1 ]
机构
[1] Univ Cattol Sacro Cuore, Ctr Comprehens Canc, Fondazione Policlinico Univ Agostino Gemelli, Oncol Med, Rome, Italy
[2] Campus Bio Medico Rome Univ, Dept Med Oncol, Rome, Italy
关键词
D O I
10.1016/j.annonc.2023.04.209
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-153
引用
收藏
页码:S69 / S69
页数:1
相关论文
共 50 条
  • [1] Focus on RAS codon 61 mutations in metastatic colorectal cancer (mCRC): A retrospective analysis
    Schietroma, Francesco
    Anghelone, Annunziato
    Valente, Giustina
    Beccia, Viria
    Caira, Giulia
    Spring, Alexia
    Trovato, Giovanni
    Di Bello, Armando
    Ceccarelli, Anna
    Chiofalo, Laura
    Perazzo, Serena
    Bensi, Maria
    Basso, Michele
    Pozzo, Carmelo
    Salvatore, Lisa
    Calegari, Maria Alessandra
    Tortora, Giampaolo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Focus on RAS Codon 61 Mutations in Metastatic Colorectal Cancer: A Retrospective Analysis
    Schietroma, Francesco
    Anghelone, Annunziato
    Valente, Giustina
    Beccia, Viria
    Caira, Giulia
    Spring, Alexia
    Trovato, Giovanni
    Di Bello, Armando
    Ceccarelli, Anna
    Chiofalo, Laura
    Perazzo, Serena
    Bensi, Maria
    Minucci, Angelo
    Urbani, Andrea
    Larocca, Luigi Maria
    Basso, Michele
    Pozzo, Carmelo
    Salvatore, Lisa
    Calegari, Maria Alessandra
    Tortora, Giampaolo
    CANCERS, 2024, 16 (05)
  • [3] Prognostic effect of RAS/BRAF mutations in patients (pts) with metastatic colorectal cancer (mCRC)
    Abid, Haisam
    Szabo, Aniko
    Taylor, Bradley W.
    Shreenivas, Aditya V.
    Chakrabarti, Sakti
    Kamgar, Mandana
    Thomas, James P.
    George, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [4] Prevalence of RAS and BRAF mutations in metastatic colorectal cancer (mCRC) patients by tumor location.
    Bylsma, Lauren C.
    Gillezeau, Christina
    Garawin, Tamer
    Kelsh, Michael Anthony
    Fryzek, Jon
    Sangare, Laura
    Lowe, Kimberly
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [5] Prognostic effect of specific RAS/BRAF mutations in patients (pts) with metastatic colorectal cancer (mCRC).
    George, Ben
    Taylor, Bradley W.
    Lasowski, Matthew
    Ritch, Paul S.
    Shreenivas, Aditya Varnam
    Chakrabarti, Sakti
    Kamgar, Mandana
    Zimmermann, Michael T.
    Reddi, Honey, V
    Urrutia, Raul
    Thomas, James P.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Atypical RAS Mutations in Metastatic Colorectal Cancer
    Pietrantonio, Filippo
    Yaeger, Rona
    Schrock, Alexa B.
    Randon, Giovanni
    Romero-Cordoba, Sandra
    Rossini, Daniele
    Fuca, Giovanni
    Ross, Jeffrey S.
    Kotani, Daisuke
    Madison, Russell
    Kim, Seung Tae
    Salvatore, Lisa
    Raimondi, Alessandra
    Pagani, Filippo
    Borelli, Beatrice
    Perrone, Federica
    Di Bartolomeo, Maria
    Miller, Vincent A.
    Ali, Siraj M.
    Lee, Jeeyun
    Yoshino, Takayuki
    de Braud, Filippo
    Falcone, Alfredo
    Hechtman, Jaclyn F.
    Cremolini, Chiara
    JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 11
  • [7] Pyrosequencing analysis of KRAS codon 61 mutations in Thai patients with advanced colorectal cancer
    Teerapakpinyo, Chinachote
    Wanthong, Phanni
    Aumchaaumchaya, Mathawee
    Chankate, Piyamai
    Kaikeaw, Warisa
    Tosakorn, Warunya
    Shaungshoti, Shanop
    ASIAN BIOMEDICINE, 2015, 9 (01) : 61 - 67
  • [8] Plasma ctDNA RAS/RAF mutations analysis for monitoring overall survival (OS) and heterogeneity in metastatic colorectal cancer patients (mCRC).
    Mancuso, Andrea Petricca
    Varchetta, Veronica
    Montagnese, Fabrizio
    Campanella, Carla
    Brandi, Rita
    Vitale, Marco
    Soda, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [9] BRCA mutations in metastatic colorectal cancer (mCRC) and response to chemotherapy
    Feng, Sophie
    Al-Showbaki, Laith
    Krzyzanowska, Monika K.
    Prince, Rebecca M.
    Stockley, Tracy
    Yu, Celeste
    Bedard, Philippe L.
    Siu, Lillian L.
    Chen, Eric Xueyu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [10] Role of EGFR, DCC and K-RAS mutations in metastatic colorectal cancer (mCRC) patients treated with cetuximab
    Mancuso, A.
    Leone, A.
    Cerbone, L.
    Zivi, A.
    Squilloni, E.
    Bertagnolio, F.
    Caristo, R.
    Gasbarra, R.
    Roberto, P.
    Sternberg, C.
    ANNALS OF ONCOLOGY, 2008, 19 : 39 - 39